Manulife (Manufacturers Life Insurance)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-36,755
Closed -$11.6M 3011
2023
Q4
$11.6M Sell
36,755
-13,467
-27% -$2.62M 0.01% 791
2023
Q3
$8.49M Buy
50,222
+6,516
+15% +$1.23M ﹤0.01% 885
2023
Q2
$9.48M Sell
43,706
-5,479
-11% -$1.17M 0.01% 813
2023
Q1
$8.93M Buy
49,185
+2,043
+4% +$391K 0.01% 839
2022
Q4
$9.18M Buy
47,142
+2,198
+5% +$471K 0.01% 821
2022
Q3
$10.1M Buy
44,944
+12,938
+40% +$2.62M 0.01% 787
2022
Q2
$4.02M Buy
32,006
+1,392
+5% +$160K ﹤0.01% 1190
2022
Q1
$3.8M Buy
30,614
+19,251
+169% +$2.17M ﹤0.01% 1315
2021
Q4
$1.48K Sell
11,363
-117
-1% -$15.1K ﹤0.01% 1620
2021
Q3
$1.4M Sell
11,480
-1,174
-9% -$136K ﹤0.01% 1642
2021
Q2
$1.44M Buy
12,654
+3,485
+38% +$407K ﹤0.01% 1770
2021
Q1
$1.1M Sell
9,169
-543
-6% -$61.5K ﹤0.01% 1819
2020
Q4
$987K Buy
9,712
+281
+3% +$26K ﹤0.01% 1819
2020
Q3
$729K Hold
9,431
﹤0.01% 1807
2020
Q2
$1M Buy
9,431
+2,681
+40% +$233K ﹤0.01% 1613
2020
Q1
$486K Buy
+6,750
New +$577K ﹤0.01% 1854

Other funds holding KRTX

Manulife (Manufacturers Life Insurance)'s KRTX Position: Q1 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 36,755 shares — an estimated $11.6M sold.

Manulife (Manufacturers Life Insurance) first reported a position in KRTX in Q1 2020 and held it in 16 quarters. The position peaked at $11.6M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 36,755 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $11.6M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
  • Manulife (Manufacturers Life Insurance)'s Karuna Therapeutics, Inc. Common Stock position peaked at $11.6M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2024, filed 14 May 2024.